1152174

Takeda Pharmaceuticals U.S.A. — FEI 3016938816

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Lexington, MA (United States)

Additional Details

Sponsor, Contract Research Organization